Achievable Cost Saving and Cost-Effective Thresholds for Diabetes Prevention Lifestyle Interventions in People Aged 65 Years and Older: A Single-Payer Perspective

Journal of the Academy of Nutrition and Dietetics

Volumn 112, Issue 11, 2012, Pages 1747-1754

  Anderson, Jennifer M ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cost effectiveness; Diabetes prevention; Medical nutrition therapy; Prediabetes

Indexed keywords

AGED; ARTICLE; COST; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DIET THERAPY; ECONOMICS; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE; MALE; MEDICARE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; STANDARD; UNITED STATES;

AGED; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH CARE COSTS; HEALTH CARE REFORM; HUMANS; LIFE STYLE; MALE; MEDICARE; NUTRITION THERAPY; OUTCOME ASSESSMENT (HEALTH CARE); PREDIABETIC STATE; RISK REDUCTION BEHAVIOR; SENSITIVITY AND SPECIFICITY; SINGLE-PAYER SYSTEM; UNITED STATES;

EID: 84867952137     PISSN: 22122672     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jand.2012.08.033     Document Type: Article

References (49)

1. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011 2011, Centers for Disease Control and Prevention, US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA.
2. Adler G.S. Diabetes in the Medicare aged population, 2004. Health Care Financ Rev 2008, 29(3):69-79.
3. DeVol R., Bedroussian A. An Unhealthy America: The Economic Burden of Chronic Disease. Executive Summary 2007, Milken Institute, Santa Monica, CA.
4. Schmier J.K., Covert D.W., Lau E.C., Matthews G.P. Medicare expenditures associated with diabetes and diabetic retinopathy. Retina 2009, 29(2):199-206.
5. Thorpe K.E., Ogden L.L., Galactionova K. Chronic conditions account for rise in Medicare spending from 1987 to 2006. Health Aff (Millwood) 2010, 29(4):718-724.
6. Wolf A.M., Siadaty M.S., Crowther J.Q., et al. Impact of lifestyle intervention on lost productivity and disability: Improving control with activity and nutrition. J Occup Environ Med 2009, 51(2):139-145.
7. Knowler W.C., Fowler S.E., et al. 10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study. Lancet 2009, 374(9707):1677-1686. Diabetes Prevention Program Research Group.
8. Knowler W.C., Barrett-Connor E., Fowler S.E., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346(6):393-403.
9. Ratner R., Goldberg R., Haffner S., et al. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care 2005, 28(4):888-894.
10. Tuomilehto J., Lindstrom J., Eriksson J.G., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344(18):1343-1350.
11. Uusitupa M., Louheranta A., Lindstrom J., et al. The Finnish Diabetes Prevention Study. Br J Nutr 2000, 83(suppl 1):S137-S142.
12. Lindstrom J., Ilanne-Parikka P., Peltonen M., et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: Follow-up of the Finnish diabetes prevention study. Lancet 2006, 368(9548):1673-1679.
13. Pan X.R., Li G.W., Hu Y.H., et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study. Diabetes Care 1997, 20(4):537-544.
14. Li G., Zhang P., Wang J., et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing diabetes prevention study: A 20-year follow-up study. Lancet 2008, 371(9626):1783-1789.
15. Matchar D., Keefe F., McCrory D., et al. Use of Behavioral Therapies for Treatment of Medical Disorders: Part-1 Impact on Management of Patients with Diabetes Mellitus 2004, Agency for Healthcare Research and Quality, Rockville, MD.
16. Nield L., Summerbell C.D., Hooper L., Whittaker V., Moore H. Dietary advice for the prevention of type 2 diabetes mellitus in adults. Cochrane Database Syst Rev 2008, (3). CD005102.
17. Penn L., White M., Oldroyd J., Walker M., Alberti K.G., Mathers J.C. Prevention of type 2 diabetes in adults with impaired glucose tolerance: The European diabetes prevention RCT in Newcastle upon Tyne, UK. BMC Public Health 2009 Sep 16, 9:342-356.
18. Pastors J.G. Medications or lifestyle change with medical nutrition therapy. Curr Diab Rep 2003, 3(5):386-391.
19. Pastors J.G., Franz M.J., Warshaw H., Daly A., Arnold M.S. How effective is medical nutrition therapy in diabetes care?. J Am Diet Assoc 2003, 103(7):827-831.
20. Franz M.J., Monk A., Barry B., et al. Effectiveness of medical nutrition therapy provided by dietitians in the management of non-insulin-dependent diabetes mellitus: A randomized, controlled clinical trial. J Am Diet Assoc 1995, 95(9):1009-1017.
21. Kulkarni K. Diets do not fail: The success of medical nutrition therapy in patients with diabetes. Endocr Pract 2006, 12(suppl 1):121-123.
22. Ackermann R.T., Marrero D.G. Adapting the diabetes prevention program lifestyle intervention for delivery in the community: The YMCA model. Diabetes Educ 2007, 33(1):69-78.
23. McBride P.E., Einerson J.A., Grant H., et al. Putting the Diabetes Prevention Program into practice: A program for weight loss and cardiovascular risk reduction for patients with metabolic syndrome or type 2 diabetes mellitus. J Nut Health Aging 2008, 12(10):745S-749S.
24. Makrilakis K., Liatis S., Grammatikou S., Perrea D., Katsilambros N. Implementation and effectiveness of the first community lifestyle intervention programme to prevent type 2 diabetes in Greece. The DE-PLAN study. Diabet Med 2009, 27(4):459-465.
25. Teutsch S. The cost of preventing diabetes: What do we know and what do we need to know?. Diabetes Care 2003, 26(1):238-239.
26. Dalziel K., Segal L. Time to give nutrition interventions a higher profile: Cost-effectiveness of 10 nutrition interventions. Health Promot Int 2007, 22(4):271-283.
27. Franz M.J. Evidence-based medical nutrition therapy for diabetes. Nutr Clin Pract 2004, 19(2):137-144.
28. Franz M.J., Splett P.L., Monk A., et al. Cost-effectiveness of medical nutrition therapy provided by dietitians for persons with non-insulin-dependent diabetes mellitus. J Am Diet Assoc 1995, 95(9):1018-1024.
29. Health economics of diabetes prevention International Diabetes Federation, Accessed April 10, 2012. http://www.idf.org/Diabetes%20Prevention/health-economics.
30. Eddy D.M., Schlessinger L., Kahn R. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann Intern Med 2005, 143(4):251-264.
31. Herman W.H., Hoerger T.J., Brandle M., et al. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med 2005, 142(5):323-332.
32. Code of Federal Regulations: Title 45: Public Welfare; Department of Health and Human Services: Part 46: Protection of Human Subjects US Department of Health and Human Services, Accessed April 13, 2012. http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html#46.101(b).
33. Older Americans 2010: Key Indicators of Well-Being 2010, Federal Interagency Forum on Aging-Related Statistics, US Government Printing Office, Washington, DC.
34. Economic costs of diabetes in the US in 2007. Diabetes Care 2008, 31(3):596-615. American Diabetes Association.
35. Honeycutt A.A., Segel J.E., Hoerger T.J., Finkelstein E.A. Comparing cost-of-illness estimates from alternative approaches: An application to diabetes. Health Serv Res 2009, 44(1):303-320.
36. Narayan K.M., Boyle J.P., Thompson T.J., Sorensen S.W., Williamson D.F. Lifetime risk for diabetes mellitus in the United States. JAMA 2003, 290(14):1884-1890.
37. Chatterjee R., Lipscomb J., Narayan K.M.V., Phillips L.S. Screening adults for pre-diabetes and diabetes may be cost-saving. Diabetes Care 2010, 33(7):1484-1490.
38. Herman W.H., Brandle M., Zhang P., et al. Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care 2003, 26(1):36-47.
39. Health, United States, 2008 2009, National Center for Health Statistics, US Government Printing Office, Hyattsville, MD.
40. Wylie-Rosett J., Herman W.H., Goldberg R.B. Lifestyle intervention to prevent diabetes: Intensive and cost effective. Curr Opin Lipidol 2006, 17(1):37-44.
41. Braithwaite R.S., Meltzer D.O., King J.T., Leslie D., Roberts M.S. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?. Med Care 2008, 46(4):349-356.
42. Palmer A.J., Valentine W.J., Ray J.A. Cost-effectiveness studies of diabetes prevention in high-risk patients. Expert Rev Pharmacoecon Outcomes Res 2004, 4(4):393-402.
43. Bertram M.Y., Lim S.S., Barendregt J.J., Vos T. Assessing the cost-effectiveness of drug and lifestyle intervention following opportunistic screening for pre-diabetes in primary care. Diabetologia 2010, 53(5):875-881.
44. Jacobs-van der Bruggen M.A.M., Bos G., Bemelmans W.J., Hoogenveen R.T., Vijgen S.M., Baan C.A. Lifestyle interventions are cost-effective in people with different levels of diabetes risk: Results from a modeling study. Diabetes Care 2007, 30(1):128-134.
45. Neumann A., Schwarz P., Lindholm L. Estimating the cost-effectiveness of lifestyle intervention programmes to prevent diabetes based on an example from Germany: Markov modeling. Cost Eff Resour Alloc 2011, 9(1):17-29.
46. Palmer A.J., Roze S., Valentine W.J., Spinas G.A., Shaw J.E., Zimmet P.Z. Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: Modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom. Clin Ther 2004, 26(2):304-321.
47. Ramachandran A., Snehalatha C., Yamuna A., Mary S., Ping Z. Cost-effectiveness of the interventions in the primary prevention of diabetes among Asian Indians. Diabetes Care 2007, 30(10):2548-2552.
48. Lindstrom J., Louheranta A., Mannelin M., et al. The Finnish diabetes prevention study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 2003, 26(12):3230-3236.
49. Perreault L., Kahn S.E., Christophi C.A., Knowler W.C., Hamman R.F. Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program. Diabetes Care 2009, 32(9):1583-1588. Diabetes Prevention Program Research Group.